ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2900

Impaired TCR Signaling Paves the Way for Cytokine Hyper-Responsiveness in Arthritogenic T Cells

Judith Ashouri1, Lih-Yun Hsu1, Dmitry Rychkov2, Marina Sirota2, Lisa Lattanza3, Eric Hansen3, Julie Zikherman1 and Arthur Weiss1, 1Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center, Department of Medicine, Division of Rheumatology, University of California, San Francisco, San Francisco, CA, 2Pediatrics, Institute for Computational Health Sciences, University of California, San Francisco, San Francisco, CA, 3Orthopedic Surgery, University of California, San Francisco, San Francisco, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: animal models and rheumatoid arthritis, antigen RA, IL-6, rheumatoid arthritis, synovium, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, October 24, 2018

Title: 6W009 ACR Abstract: RA–Etiology & Pathogenesis II (2898–2903)

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: The inability to identify relevant arthritogenic CD4 T cells in patients and in murine disease models has limited our understanding of disease initiating events in rheumatoid arthritis (RA). To overcome this limitation, we took advantage of the dynamic expression pattern of Nur77 (Nr4a1)—a sensitive and specific marker of TCR signaling that is insensitive to cytokine stimulation—to identify antigen-activated CD4 T cells in human RA and the SKG mouse model of autoimmune arthritis.

Methods: We used intracellular flow cytometry to identify T cells that express Nur77 protein in synovial tissue and blood from patients with seropositive RA or osteoarthritis (OA), as well as in the SKG arthritis model. A fluorescent reporter (eGFP) of Nur77 expression was backcrossed into SKG mice (SKGNur) to identify and study arthritogenic T cells in this model. Functional and signaling differences between CD4 T cells that expressed the highest and lowest amounts of eGFP (GFPhi and GFPlo, respectively) were compared using in vitro assays, adoptive transfer, and gene expression assays. We searched general public repository databases for available transcriptome data from human RA synovium (13 studies met inclusion criteria comprising over 300 synovial samples) to examine candidate gene expression profiles.

Results: Nur77 expression was specifically enriched in a subset of synovial CD4 T cells from patients with RA (Fig 1). This suggested the presence of antigen-activated T cells in RA synovial tissue. This was confirmed in the SKG mouse. Higher levels of Nur77-eGFP (GFPhi) in SKGNur CD4 T cells marked their autoreactivity and arthritogenic potential and their ability to more readily differentiate into IL-17 producing cells (Fig 2). T cells exhibiting this heightened autoreactivity still had diminished TCR signaling, perhaps due to upregulation of inhibitory receptors. Moreover, the enhanced autoreactivity was associated with upregulation of IL-6 cytokine signaling machinery, but a reduced amount of expression of suppressor of cytokine signaling 3 (SOCS3)—a key negative regulator of IL-6 signaling. As a result, the more autoreactive GFPhi CD4 T cell population from SKGNur mice was uniquely hyper-responsive to IL-6. Consistent with findings from SKGNur mice, SOCS3 expression was similarly downregulated in RA synovium.

Conclusion: This suggests that, despite impaired TCR signaling, autoreactive T cells exposed to chronic antigen stimulation exhibit heightened sensitivity to IL-6 receptor signaling which contributes to their arthritogenicity in SKG mice, and perhaps in patients with RA.


Disclosure: J. Ashouri, None; L. Y. Hsu, None; D. Rychkov, None; M. Sirota, None; L. Lattanza, None; E. Hansen, None; J. Zikherman, None; A. Weiss, None.

To cite this abstract in AMA style:

Ashouri J, Hsu LY, Rychkov D, Sirota M, Lattanza L, Hansen E, Zikherman J, Weiss A. Impaired TCR Signaling Paves the Way for Cytokine Hyper-Responsiveness in Arthritogenic T Cells [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/impaired-tcr-signaling-paves-the-way-for-cytokine-hyper-responsiveness-in-arthritogenic-t-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impaired-tcr-signaling-paves-the-way-for-cytokine-hyper-responsiveness-in-arthritogenic-t-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology